Consulting firm Technology Commercialization Group (TCG) is joining forces with a German firm in a partnership aimed at smoothing the path to market for new drugs and medical devices on both sides of the Atlantic.
Durham-based TCG specializes in helping European companies commercialize products to the U.S. market. The company is now partnering with Heidelberg, Germany consulting firm Life Science Consulting Network (LSCN). From its base in Germany, LSCN has focused on helping companies commercialize their products in Europe. No financial terms of the partnership were disclosed.
While the United States and Europe are the largest markets for new drugs and medical devices, they have different regulatory, reimbursement and legal environments. The firms say they will now be able to work together supporting the transatlantic commercialization efforts of their respective clients.